19 A recent study of PFAS and antibody response to different SARS-CoV-2 vaccines in 415 workers at two 3M Company facilities showed borderline significant negative associations for PFOS. 20 The EFSA assessment highlighted the lack of data on PFAS effects in prospective vaccination studies covering various types of vaccines and age groups. 3 Efforts to control the COVID-19 pandemic by vaccination provide a unique opportunity to prospectively study effects of PFAS on primary vaccine responses in adults.
← all excerpts
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden.
1
—
—